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Case Presentations:
Eosinophilic Pustular Folliculitis 
Discussion:
Eosinophilic pustular folliculitis (EPF) was originally described by Ofuji in 1965 with the 
first case presenting as folliculocentric pustules distributed on the face, torso, and arms of 
a Japanese female. Since the initial description, three distinct subtypes of EPF now exist.  
These types include the originally described classic variant seen in the Japanese population, 
an immunosuppressed (EPF-IS) variant, and a rare infantile form.
All three subtypes of EPF are more commonly seen in men compared to women.  The classic 
form has a peak incidence between the third and fourth decades. It presents as recurrent 
follicular papules and pustules located on the face, trunk, or extremities and more rarely the 
palmoplantar surfaces. Post inflammatory hyperpigmentation is common and leukocytosis 
with eosinophilia is seen in up to 35% of patients. 
The IS subtype demonstrates intensely pruritic discrete erythematous follicular papules with 
palmoplantar sparing, and infrequent annular or circinate plaque forms. Frequently with the 
IS-HIV form, CD4 cell counts are below 300 cells/μl (500-1200 cells/μl) and 25%-50% of 
patients have lymphopenia with eosinophilia. The IS-Heme form has been predominantly 
associated with hematologic malignancies including non-Hodgkin lymphoma, leukemia (ALL 
and AML), and myelodysplastic syndrome.  For all of these cases except two, EPF followed 
bone marrow transplant, peripheral blood stem cell transplant, or chemotherapy initiation. 
To date, no reported cases of EPF presenting prior to the diagnosis of mantle cell lymphoma 
have been described. 
Our patient cases represent variants of immunosuppression related eosinophilic pustular 
folliculitis.  Patient A presented initially with EPF a month before being diagnosed with 
mantle cell lymphoma.  Patient B had a more diffuse clinical presentation secondary to his 
underlying chronic immunosuppression. 
Histopathologically, all three identified forms of EPF show acute and chronic 
lymphoeosinophilic infiltrate concentrated at the follicular isthmus.  In addition, scattered 
mononuclear cells, eosinophils, and neutrophils are typically found within the pilar outer root 
sheath, sebaceous glands, and ducts.  Follicular mucinosis is seen in up to 40% of cases as 
well as follicular destruction.    
The pathophysiology is believed to represent a Th2 predominant pathway (IL-3, IL-5, and 
IL-13) with eotaxin-3 expression, which promote eosinophil recruitment, inflammation, and 
tissue damage seen in EPF.
Multiple therapeutic modalities have been reported for the treatment of EPF. For all 
three types, moderate to high potency topical corticosteroids are considered first line of 
therapy while UVB phototherapy 2-3 times weekly remains the gold standard treatment.  
Indomethacin (50- 75mg/ day) is first line treatment for classic EPF due to its ability to limit 
the chemoattraction of eosinophils. Other potential treatments include prednisone, psoralen 
plus UVA, cetirizine, metronidazole, minocycline, itraconazole, dapsone, systemic retinoids, 
topical tacrolimus, and topical permethrin.
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Patient: 52 year-old Caucasian male  
History of Present Illness: Patient presented with a 1-month history 
of a pruritic red rash on his face, neck, shoulders, and chest.  The patient had 
already completed a course of azithromycin, IM triamcinolone, and oral prednisone 
with only minor improvement.  He experienced initial improvement in his itching with 
a decrease in the number of skin lesions.  One month after his initial presentation, 
he began to experience difficulty swallowing and fatigue.  He experienced swollen 
tonsils with neck and axillary lymphadenopathy and was diagnosed with mantle cell 
lymphoma.
Medical History/Surgical History: Prostate cancer  
Current Medications: Indomethacin, triamcinolone cream, and hyper 
CVAD rituximab chemotherapy 
Previous Treatments: Azithromycin, IM triamcinolone, oral prednisone, 
and doxycycline 
Physical Examination: Multiple pink to red folliculocentric papules 
and pustules admixed with edematous pink plaques scattered on the face, neck, 
shoulders, and back.  Palms, soles, and oral mucosa were clear.
Laboratory Data: Serum HIV: negative, CBC and CMP normal except as 
follows: eosinophils 8% (0-4%)
Studies: CT: neck, chest, and abdomen demonstrated diffuse lymphadenopathy. 
PET/CT: extensive metabolically active lymphoma in multiple nodal groups above 
and below the diaphragm with lymphomatous involvement of spleen. Axillary LN Bx: 
mantle cell lymphoma (CD4:CD8 1:1, CD45 (-), CD20 (+), CD5 (+))
Biopsy:  Advanced Dermatology Associates, LTD (S13-16789, 5/20/2013) 
Forehead: “Eosinophilic follicular spongiosis with intrafollicular Langerhans cell 
microgranulomas along with superficial and deep perivascular, interstitial, and 
perifollicular chronic inflammation.”
Figure 1A: Pink to red edematous papules and plaques on the face
Figure 1B: Closer view showing pustules on the right forehead
Figure 1C and 1D: H&E, Follicular spongiosis with perifollicular, interstitial, and perivascular 
lymphohistiocytic infiltration with numerous eosinophils
Figure 2A and Figure 2B: Hyperpigmented lichenified papules and nodules on the face, chest, and 
abdomen 
Figure 2C and 2D: H&E, Follicular spongiosis with overlying focal epidermal spongiosis, superficial and 
mid dermal lymphohiostiocytic inflammation, and abundant eosinophils
Patient: 64-year-old African American male  
History of Present Illness: Patient was admitted to the hospital for lower 
extremity deep vein thrombosis (DVT) in addition to a six-month history of a diffuse pruritic 
rash on his head, neck, trunk, and proximal extremities. Skin biopsy performed 3 months 
prior was consistent with a spongiotic drug reaction.  However the skin rash did not 
improve after adjusting his medications. He describes the rash as stable and does admit to 
slight improvement with topical triamcinolone use at home. 
Medical History/Surgical History: Chronic kidney disease s/p renal 
transplant with chronic allograft nephropathy and episodes of acute graft rejection, history 
of upper and lower extremity DVTs, hypertension, anemia of chronic disease, congestive 
heart failure, chronic atrial fibrillation, morbid obesity, and chronic immunosuppression 
Current Medications: Prednisone, topical hydrocortisone, hydroxyzine, 
cinacalcet, tacrolimus, metoprolol tartate, methocarbamol, simvastatin, warfarin, 
furosemide and fluticasone propionate/ salmeterol inhaled
Previous Treatments: Triamcinolone ointment 
Physical Examination: Scattered hyperpigmented and firm folliculocentric 
papules and nodules on the head, neck, chest, abdomen, back, proximal thighs, and arms.  
Palms, soles, and oral mucosa are clear.
Laboratory Data: CBC: hemoglobin 11(13.5-18 g/dL) hematocrit 35 (40-54%) 
wbc 16 (4.5-11 thou/cmm), absolute eosinophils 9 (0-0.5 thou/cmm), eosinophils 54% (0-
4%), creatinine 2.9 (0.7-1.5 mg/dL), GFR 22 (>60), UA wnl, sirolimus and tacrolimus drug 
levels wnl, serum HIV negative, negative for translocation (9:22) and BCR/ABL transcript 
product 
Biopsy: Health Network Laboratories (S13-29505, 9/4/2013):  Right shoulder: 
“Follicular spongiosis associated with exocytosis of lymphocytes and eosinophils.  There 
is superficial to mid dermal lymphohistiocytic infiltrate with numerous eosinophils. Focal 
spongiosis of overlying epidermis with a Langerhans cell microgranuloma.”
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